Full Text View
Tabular View
No Study Results Posted
Related Studies
Sevoflurane-Remifentanil Anaesthesia. The Risk of Post Operative Nausea
This study has been completed.
Study NCT00452855   Information provided by Viborg Hospital
First Received: March 26, 2007   Last Updated: March 28, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Nausea
Vomiting
Additional conditions recognized in this trial
Postoperative Nausea and Vomiting
More general conditions related to this trial
Pathologic Processes
Postoperative Complications
Signs and Symptoms
Signs and Symptoms, Digestive
Additional drug interventions recognized in this trial
Anesthetics
Remifentanil
Sevoflurane
More general drug interventions related to this trial
Analgesics
Analgesics, Opioid
Anesthetics, General
Anesthetics, Inhalation
Anesthetics, Intravenous
Central Nervous System Agents
Central Nervous System Depressants
Hematologic Agents
Hypnotics and Sedatives
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Viborg Hospital
Nielsen, Jens OD, M.D.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services